AMRUTANJAN HEALTH CARE
|
AMRUTANJAN HEALTH CARE Last 5 Year Financial Ratios History
[Standalone]
| Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
|---|---|---|---|---|---|
| Operational & Financial Ratios | |||||
| Earnings Per Share (Rs) | 15.56 | 13.63 | 22.99 | 20.93 | 8.58 |
| CEPS(Rs) | 17.65 | 15.41 | 24.28 | 22.19 | 10.07 |
| DPS(Rs) | 4.60 | 4.60 | 4.60 | 4.20 | 2.10 |
| Book NAV/Share(Rs) | 99.92 | 99.12 | 90.49 | 73.53 | 54.54 |
| Tax Rate(%) | 27.40 | 25.74 | 25.82 | 25.29 | 27.20 |
| Margin Ratios | |||||
| Core EBITDA Margin(%) | 12.32 | 11.73 | 19.11 | 20.20 | 11.79 |
| EBIT Margin(%) | 14.77 | 14.19 | 22.46 | 24.79 | 13.31 |
| Pre Tax Margin(%) | 14.71 | 14.13 | 22.32 | 24.61 | 13.18 |
| PAT Margin (%) | 10.68 | 10.49 | 16.56 | 18.38 | 9.59 |
| Cash Profit Margin (%) | 12.11 | 11.87 | 17.49 | 19.49 | 11.26 |
| Performance Ratios | |||||
| ROA(%) | 12.47 | 11.32 | 21.78 | 25.94 | 13.05 |
| ROE(%) | 15.54 | 14.37 | 28.03 | 32.69 | 16.44 |
| ROCE(%) | 21.47 | 19.38 | 37.93 | 44.00 | 22.80 |
| Asset Turnover(x) | 1.17 | 1.08 | 1.32 | 1.41 | 1.36 |
| Sales/Fixed Asset(x) | 5.63 | 6.26 | 9.31 | 8.50 | 7.09 |
| Working Capital/Sales(x) | 1.87 | 1.93 | 2.06 | 1.95 | 3.01 |
| Efficiency Ratios | |||||
| Fixed Capital/Sales(x) | 0.18 | 0.16 | 0.11 | 0.12 | 0.14 |
| Receivable days | 35.05 | 34.26 | 25.15 | 24.19 | 41.46 |
| Inventory Days | 25.01 | 26.36 | 19.54 | 22.58 | 26.73 |
| Payable days | 89.00 | 108.19 | 102.26 | 93.75 | 95.43 |
| Valuation Parameters | |||||
| PER(x) | 39.77 | 42.19 | 34.53 | 27.15 | 38.45 |
| PCE(x) | 35.05 | 37.31 | 32.69 | 25.61 | 32.76 |
| Price/Book(x) | 6.19 | 5.80 | 8.77 | 7.73 | 6.05 |
| Yield(%) | 0.74 | 0.80 | 0.58 | 0.74 | 0.64 |
| EV/Net Sales(x) | 4.18 | 4.24 | 5.50 | 4.57 | 3.55 |
| EV/Core EBITDA(x) | 25.81 | 27.26 | 23.51 | 17.66 | 23.71 |
| EV/EBIT(x) | 28.33 | 29.89 | 24.49 | 18.45 | 26.68 |
| EV/CE(x) | 6.11 | 5.54 | 6.45 | 5.62 | 4.62 |
| M Cap / Sales | 4.25 | 4.43 | 5.72 | 4.99 | 3.69 |
| Growth Ratio | |||||
| Net Sales Growth(%) | 10.96 | -6.46 | 21.93 | 27.29 | 3.20 |
| Core EBITDA Growth(%) | 15.53 | -37.78 | 10.20 | 120.08 | 2.65 |
| EBIT Growth(%) | 15.46 | -40.91 | 10.50 | 137.11 | -0.27 |
| PAT Growth(%) | 12.90 | -40.71 | 9.80 | 143.95 | 2.32 |
| EPS Growth(%) | 14.15 | -40.71 | 9.80 | 143.95 | 2.32 |
| Financial Stability Ratios | |||||
| Total Debt/Equity(x) | - | - | - | - | - |
| Current Ratio(x) | 4.23 | 4.13 | 3.55 | 4.28 | 3.22 |
| Quick Ratio(x) | 3.82 | 3.67 | 3.21 | 3.94 | 2.61 |
| Interest Cover(x) | 247.90 | 241.99 | 156.66 | 139.35 | 102.57 |
| Total Debt/Mcap(x) | - | - | - | - | - |
Compare Financial Ratios of peers of AMRUTANJAN HEALTH CARE
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| AMRUTANJAN HEALTH CARE | ₹1,977.9 Cr | -4.3% | -8.9% | 19.1% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹418,936.0 Cr | -5.8% | -3.2% | 35.1% | Stock Analytics | |
| DIVIS LABORATORIES | ₹152,157.0 Cr | -2.8% | -3.6% | 44.7% | Stock Analytics | |
| CIPLA | ₹116,200.0 Cr | -3.9% | -0.5% | 13.9% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹111,325.0 Cr | -1.2% | 7.1% | 17.8% | Stock Analytics | |
| ZYDUS LIFESCIENCES | ₹98,037.4 Cr | -2.7% | -0.1% | 40.9% | Stock Analytics | |
AMRUTANJAN HEALTH CARE Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| AMRUTANJAN HEALTH CARE | -4.3% |
-8.9% |
19.1% |
| SENSEX | -2.1% |
-6.4% |
7% |
You may also like the below Video Courses
